Zhejiang Xinguang Pharmaceutical Co Ltd
300519
Company Profile
Business description
Zhejiang Xinguang Pharmaceutical Co Ltd manufactures and operates pharmaceuticals. Its products cover cardiovascular, digestive, respiratory, orthopaedic, health food, urinary, and tonic systems and remove heat and toxic substances. It produces oral solutions, tablets, capsules, granules, powders, and syrup drugs.
Contact
No.25, Huancheng West Road
Zhejiang Province
Shengzhou312400
CHNT: +86 57583292898
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
309
Stocks News & Analysis
stocks
AI driving growth for ASX tech share
ASX tech share raises funds to facilitate customer AI spend.
stocks
OpenAI is going public as the worst value among its peers
Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks
Wide moat healthcare leader remains undervalued
ASX healthcare giant expected to see uptick in demand from emerging markets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,824.80 | 67.50 | 0.77% |
| CAC 40 | 8,243.00 | 43.71 | 0.53% |
| DAX 40 | 24,616.41 | 0.19 | 0.00% |
| Dow JONES (US) | 50,919.98 | 133.97 | 0.26% |
| FTSE 100 | 10,286.19 | 87.01 | -0.84% |
| HKSE | 24,565.90 | 91.16 | -0.37% |
| NASDAQ | 25,755.04 | 174.62 | -0.67% |
| Nikkei 225 | 65,416.63 | 1,392.03 | 2.17% |
| NZX 50 Index | 13,204.08 | 165.84 | 1.27% |
| S&P 500 | 7,389.15 | 16.58 | -0.22% |
| S&P/ASX 200 | 8,604.20 | 70.70 | 0.83% |
| SSE Composite Index | 4,010.03 | 50.69 | 1.28% |